Proteomics International announced a capital raising of A$3.0 million via a heavily oversubscribed placement. The company described the placement as successful and heavily oversubscribed. Management said the proceeds leave Proteomics well-funded into CY20 and beyond. The raise strengthens the company's balance sheet. Company statements say the stronger balance sheet is intended to support any potential future licensing or partnering discussions around PromarkerD.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2019